Group ALS (-4,+1d) CsA (0-20d) GFP+-ASC (+7,+10,+14) Allograft survival day 1 － － － 9, 9, 11, 8, 10, 14 2 ＋ ＋ ＋ 105*, >150, >150, >150, >150, >150 *Expired during sampling, but no rejection of allograft

Table 1: Analysis of allo-transplant survival days in a rodent hind-limb VCA model.